Transcriptomic Profiling of Tumor Aggressiveness in Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms

被引:8
|
作者
Haugvik, Sven-Petter [1 ,2 ]
Vodak, Daniel [3 ]
Haugom, Lisbeth [4 ,5 ]
Hovig, Eivind [3 ,4 ,6 ]
Gladhaug, Ivar Prydz [1 ,2 ]
Heim, Sverre [2 ,4 ,5 ]
Micci, Francesca [4 ,5 ]
机构
[1] Oslo Univ Hosp, Dept Hepatopancreatobiliary Surg, Postbox 4950, N-0424 Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway
[4] Oslo Univ Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway
[5] Univ Oslo, Ctr Canc Biomed, Oslo, Norway
[6] Univ Oslo, Dept Informat, Oslo, Norway
关键词
neuroendocrine neoplasms; pancreatic neuroendocrine tumor; transcriptomic profiling; cell proliferation; GENE-EXPRESSION; ENDOCRINE TUMORS; THERAPEUTIC TARGETS; CELL-PROLIFERATION; MTOR PATHWAY; CANCER CELLS; CATHEPSIN-E; GROWTH; INHIBITION; METASTASES;
D O I
10.1097/MPA.0000000000000610
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: The aim of the study was to compare RNA sequencing data of sporadic nonfunctioning pancreatic neuroendocrine neoplasms (PNENs) to identify gene expression patterns that may be important for molecular differentiation of tumor aggressiveness. Methods: RNA sequencing was performed on samples of sporadic nonfunctioning PNENs, grouped as tumors with mild behavior (nonmetastatic and Ki67 < 5%) or aggressive behavior (metastatic and Ki67 >= 5%), on an Illumina Genome Analyzer II platform. Bioinformatic analyses were performed on the resulting data. Results: Of 22,810 identified transcripts from protein-coding genes, a set of 309 genes were significantly differentially expressed between the 2 groups, of which 166 were upregulated and 143 downregulated in the aggressive disease group. Among the top protein-coding upregulated genes, we found genes encoding proteins involved in DNA packaging, ability to taste, chromosome structuring, cytoskeleton structuring, and cell-cell signaling. Among the top protein-coding downregulated genes, we found genes encoding proteins involved in neuronal differentiation, cytoskeleton structuring, cell-cell signaling, and immunological processes. Conclusions: A higher degree of tumor aggressiveness in sporadic nonfunctioning PNENs seems to be associated with upregulation of genes involved in regulation of the cell cycle and cell division. Small sample size and lack of a replication set are limitations of this study.
引用
收藏
页码:1196 / 1203
页数:8
相关论文
共 50 条
  • [41] Resection strategies for neuroendocrine pancreatic neoplasms
    Watzka, F. M.
    Laumen, C.
    Fottner, C.
    Weber, M. M.
    Schad, A.
    Lang, H.
    Musholt, T. J.
    LANGENBECKS ARCHIVES OF SURGERY, 2013, 398 (03) : 431 - 440
  • [42] Surgical management of pancreatic neuroendocrine neoplasms
    Alberti, Piero
    Martin, David
    Gemenetzis, Georgios
    Parks, Rowan
    LAPAROSCOPIC ENDOSCOPIC AND ROBOTIC SURGERY, 2023, 6 (03): : 83 - 90
  • [43] Contrast-Enhanced Sonography of Nonfunctioning Pancreatic Neuroendocrine Tumors
    Malago, Roberto
    D'Onofrio, Mirko
    Zamboni, Giulia A.
    Faccioli, Niccolo
    Falconi, Massimo
    Boninsegna, Letizia
    Mucelli, Roberto Pozzi
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (02) : 424 - 430
  • [44] Association between preoperative Vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET)
    Andreasi, Valentina
    Partelli, Stefano
    Manzoni, Marco
    Muffatti, Francesca
    Colombo, Barbara
    Corti, Angelo
    Falconi, Massimo
    PANCREATOLOGY, 2019, 19 (01) : 57 - 63
  • [45] Association between Preoperative Vasostatin-1 and Pathological Features of Aggressiveness in Localized Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNET)
    Andreasi, V
    Partelli, S.
    Manzoni, M.
    Muffatti, F.
    Mazza, M.
    Colombo, B.
    Corti, A.
    Falconi, M.
    NEUROENDOCRINOLOGY, 2019, 108 : 111 - 111
  • [46] Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors
    Irene Y. Zhang
    Jing Zhao
    Carlos Fernandez-del Castillo
    Yvonne Braun
    Shadi Razmdjou
    Andrew L. Warshaw
    Keith D. Lillemoe
    Cristina R. Ferrone
    Journal of Gastrointestinal Surgery, 2016, 20 : 277 - 283
  • [47] Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms
    Couvelard, Anne
    Scoazec, Jean-Yves
    ANNALES DE PATHOLOGIE, 2020, 40 (02) : 120 - 133
  • [48] Molecular alterations in sporadic pancreatic neuroendocrine microadenomas
    Hadano, Atsuko
    Hirabayashi, Kenichi
    Yamada, Misuzu
    Kawanishi, Aya
    Takanashi, Yumi
    Kawaguchi, Yoshiaki
    Nakagohri, Toshio
    Nakamura, Naoya
    Mine, Tetsuya
    PANCREATOLOGY, 2016, 16 (03) : 411 - 415
  • [49] The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant
    Modlin, Irvin M.
    Moss, Steven F.
    Gustafsson, Bjorn I.
    Lawrence, Ben
    Schimmack, Simon
    Kidd, Mark
    LANGENBECKS ARCHIVES OF SURGERY, 2011, 396 (08) : 1145 - 1156
  • [50] Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance
    Lee, Nam Ju
    Hruban, Ralph H.
    Fishman, Elliot K.
    ABDOMINAL RADIOLOGY, 2018, 43 (11) : 3025 - 3034